Clinical Trial Update: 68Ga-P15-041 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Prostate Bone Metastasis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluating 68Ga-P15-041 and 68Ga-PSMA-11 PET/CT imaging in patients with metastatic prostate cancer has phases 1 and 2 ongoing, with sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-P15-041
• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Prostate Cancer Metastatic | Phase 1, Phase 2 | Status: UNKNOWN